New

Global ETF Survey 2026: Answer now →

Help us improve your experience. Please confirm your investor type:

Global ETF Survey 2026

The ETF Industry Is Evolving Fast

From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey.

Take the survey

›ETF Issuers›Invesco›PSCH

PSCH

Invesco S&P SmallCap Health Care ETF

Passive ETF Equity

The PSCH Exchange Traded Fund (ETF) is provided by Invesco. It is built to track an index: S&P SmallCap 600 Capped Health Care Index. The PSCH ETF provides physical exposure, so by buying it you actually own parts of all the 75 underlying holdings. This share class generates a stream of income by distributing dividends.

$53.39

-$0.97 (-1.78%) yesterday

1:30 PM 07/31/26 Closed

1D price range

$52.57$54.24

52W price range

$37.71$54.46

YTD Perf.

+23.32%

YTD Flows

Annualized volatility

Fund AuM

€146M

Share class AuM

€146M

TTM Yield

Tracking Error

Tracking Difference

Characteristics

ISIN

US46138E1495

TER

0.29%

Inception date

4/7/2010

Issuer

Invesco

Benchmark

S&P SmallCap 600 Capped Health Care Index

Replication method

Dividend policy

Distributing

Compare similar ETFs

ETF Name	1w perf.
LFSC F/m Emerald Life Sciences Innovation ETF	+2.83%
XBI State Street SPDR S&P Biotech ETF	-0.41%
CURE Global X S&P Biotech ETF	-0.88%
SBIO ALPS Medical Breakthroughs ETF	+1.15%
XPH State Street SPDR S&P Pharmaceuticals ETF	+2.04%
BBC Virtus LifeSci Biotech Clinical Trials ETF	-0.05%
PTH Invesco DWA Healthcare Momentum ETF	-0.23%
AAKG ARK Genomic Revolution UCITS ETF	+1.10%
ARKG ARK Genomic Revolution ETF	+1.19%
IBRN iShares Neuroscience and Healthcare ETF	+0.01%
XHE State Street SPDR S&P Health Care Equipment ETF	+6.32%
FMED Fidelity Disruptive Medicine ETF	+0.31%
GNOG Global X Genomics & Biotechnology UCITS ETF	+0.81%
GNOM Global X Genomics & Biotechnology ETF	+0.81%
HELX Franklin Genomic Advancements ETF	+1.70%

API

PerformanceDec 31, 2025 - Jul 30, 2026

Flows

Join for free to unlock

Sector exposures

Data as of 06/30/26

Healthcare

100.00%

Latest PSCH news

No content available for this fund

FAQ about PSCH

PSCH is a Passive ETF. This ETF provides exposure to Small Cap US Health Care Equities.

PSCH tracks the S&P SmallCap 600 Capped Health Care Total Return Index - USD, through a full replication replication method.

PSCH carries a total expense ratio (TER) of 0.29%, indicating the annual cost for holding the fund.

PSCH was introduced to the market on April 7, 2010. It trades on United States

Invesco S&P SmallCap Health Care ETF, PSCH, is provided by Invesco. Learn more about Invesco here.

PSCH oversees €146M in assets as of July 30, 2026.

PSCH follows a distributing dividend policy, meaning it pays out income to investors. As of July 30, 2026, its 12-month trailing yield was 0.00%.

As of June 30, 2026, PSCH has significant geographic allocations in USA and Ireland.

As of June 30, 2026, PSCH focuses largely on Healthcare.

As of June 30, 2026, PSCH holds 75 positions in its portfolio, with 49.48% of assets concentrated in its top 15 holdings.

As of June 30, 2026, PSCH top three holdings include Molina Healthcare, Inc., BrightSpring Health Services, Inc. and Krystal Biotech, Inc..

The base currency of PSCH is USD.

Top 10 holdings

Data as of 06/30/26

Molina Healthcare, Inc.

5.29%

BrightSpring Health Services, Inc.

4.82%

Krystal Biotech, Inc.

4.32%

Alkermes Plc

4.06%

Glaukos Corp.

3.75%

Corcept Therapeutics, Inc.

3.69%

Protagonist Therapeutics, Inc.

3.26%

TG Therapeutics, Inc.

3.25%

PTC Therapeutics, Inc.

3.10%

Ligand Pharmaceuticals, Inc.

2.69%

Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:

More fund data
Compare up to 3 funds
More screener filters
Edit screener columns from 100+ metrics
Watchlists for saving your research
Portfolio construction and analysis
Personal dashboard for live monitoring

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight

The ETF Industry Is Evolving Fast

Invesco S&P SmallCap Health Care ETF

FAQ about PSCH

Essentials

About Trackinsight

ETF TOOLS

PLATFORM

ETF NEWS & RESEARCH

PROFESSIONAL SOLUTIONS

SOLUTIONS FOR

CONTACT US